High prices, poor access: the EU medicines market and Big Pharma
What is Big Pharma fighting for in Brussels?
09.05.2019
The pharmaceutical industry is one of the world’s most profitable, benefiting from a highly problematic model, which helps ensure many people still lack access to essential, life-saving medicines. While this has been a major issue in the global South for decades, the crisis engulfing affordable medicines is now also spreading in Europe.